ConductScience.org, home

Library / Genes

CYP2C9: cytochrome P450 family 2 subfamily C member 9

1 protein, 55 patents, 0 drugs, 0 trials, 3,903 NIH grants and 14,924 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCYP2C9HGNC
Namecytochrome P450 family 2 subfamily C member 9HGNC
NCBI Gene ID1559NCBI Gene
HGNC IDHGNC:2623HGNC
EnsemblENSG00000138109NCBI Gene
AliasesCPC9, CYP2C, CYP2C10, CYPIIC9, P450-2C9, P450IIC9NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P11712Cytochrome P450 2C949015Ensembl, GeneID, HGNCUniProt

Patents 55

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1442869P11712Espacenet
EP 4650780 A22025-11-191818P11712Espacenet
EP 4641201 A22025-10-291402P11712Espacenet
JP 2025147176 A2025-10-063878P11712Espacenet
JP 2025529142 A2025-09-046098P11712Espacenet
EP 4594342 A22025-08-06128P11712Espacenet
US 12371689 B22025-07-296098P11712Espacenet
JP 2025517969 A2025-06-121402P11712Espacenet
JP 2025517970 A2025-06-121818P11712Espacenet
JP 2025028160 A2025-02-283878P11712Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3903

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA021765Cancer Center Support Grant (CCSG)332,025NIH's project files
K24HL133373Discovery, Implementation and Mentorship in Personalized Cardiovascular Pharmacotherapy222,025NIH's project files
T32GM008425Indiana University Comprehensive Training in Clinical Pharmacology202,025NIH's project files
P30ES007033University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment182,025NIH's project files
ZIAES025034Characterization And Functional Significance Of P450 Arachidonate Epoxygenases182,025NIH's project files
U24HG010615PharmGKB172,025NIH's project files
P30CA008748Cancer Center Support Grant152,025NIH's project files
P30DK026743UCSF Liver Center152,025NIH's project files
T15LM007033Biomedical Informatics Training Program at Stanford142,025NIH's project files
U01HG006379EHR-based Genomic Discovery and Implementation [Funded Extension]132,025NIH's project files

Papers 14924

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827146PubTator, text miningPubMed
42815441PubTator, text miningPubMed
42813643PubTator, text miningPubMed
42802548PubTator, text miningPubMed
42801138PubTator, text miningPubMed
42797477PubTator, text miningPubMed
42797324PubTator, text miningPubMed
42797308PubTator, text miningPubMed
42787300PubTator, text miningPubMed
42763370PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license